Brendan Reardon

Doctoral Student, University of Limerick

Brendan Reardon is a third year PhD student with Aedin Culhane in the School of Medicine, where his research focuses on the implementation of precision cancer medicine. Specifically, he is studying and making programmatically accessible precision oncology treatment approvals for use and reimbursement in the European Union and Republic of Ireland. He is also a scientist in the Van Allen lab at Dana-Farber Cancer Institute and the lead scientist for the Molecular Oncology Almanac Moalmanac